347
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Synthesis and antitumor activity of bisindolylmaleimide and amino acid ester conjugates

Original article

, , &
Pages 36-42 | Received 09 Sep 2009, Accepted 13 Oct 2009, Published online: 01 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ke Wang & Zhan-Zhu Liu. (2014) Synthesis and cytotoxic activities of a series of novel N-methyl-bisindolylmaleimide amide derivatives. Journal of Asian Natural Products Research 16:3, pages 296-303.
Read now
Xiang-yan Li, Yan Li, Yi Zhang, Ke Wang, Xia Yuan, Jing Jin, Yan Zhang, Zhan-zhu Liu & Xiao-guang Chen. (2011) A novel bisindolymaleimide derivative (WK234) inhibits proliferation and induces apoptosis through the protein kinase Cβ pathway, in chronic myelogenous leukemia K562 cells. Leukemia & Lymphoma 52:7, pages 1312-1320.
Read now

Articles from other publishers (2)

Xiao Sun, Lin Li, Hong-guang Ma, Pu Sun, Qi-lin Wang, Ting-ting Zhang, Yue-mao Shen, Wei-ming Zhu & Xia Li. (2017) Bisindolylmaleimide alkaloid BMA-155Cl induces autophagy and apoptosis in human hepatocarcinoma HepG-2 cells through the NF-κB p65 pathway. Acta Pharmacologica Sinica 38:4, pages 524-538.
Crossref
Ke Wang, Zheng Yan, Nan Wang & Zhan Zhu Liu. (2012) Synthesis and cytotoxic activities of a series of novel N-methylbisindolylmaleimide amino acid ester conjugates. Chinese Chemical Letters 23:4, pages 462-465.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.